Hi Phil, don't blame you. Undermines the whole story when 'it's...

Hi Phil, don't blame you. Undermines the whole story when 'it's do as I say, not do as I do'. On a 1-1 issue it's a very poor outcome - they know that. They still have skin in the game, but not nearly as much as I'd like as well. Let's see how it evolves. Obviously there is far more to the ADR story however than simply what the directors buy in this issue. Jeremy still has a huge stake via Bioscience. Trudell is new investor - who knows where that might lead. AZ relationship is strong with new management based in the UK which will make things far easier. Lots of green shoots for a paltry market cap.